Advanced Technology in the Management of Diabetes: Which Comes First-Continuous Glucose Monitor or Insulin Pump?
Curr Diab Rep
; 19(8): 50, 2019 06 27.
Article
en En
| MEDLINE
| ID: mdl-31250124
ABSTRACT
PURPOSE OF REVIEW In this article, we consider advanced technologies for the management of diabetes. RECENT FINDINGS:
Specifically, we pose the question of which should come first an insulin pump (CSII) or a continuous glucose monitor (CGM)? Historical perspective on both insulin delivery and glucose measurement is provided. Recently published clinical trials are reviewed. Practical issues including quality of life, patient education, and out-of-pocket cost are discussed. Based on available evidence and clinical experience, we favor CGM as a first-line technology recommendation for the treatment of type 1 diabetes (T1D).Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Automonitorización de la Glucosa Sanguínea
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Revista:
Curr Diab Rep
Asunto de la revista:
ENDOCRINOLOGIA
Año:
2019
Tipo del documento:
Article
País de afiliación:
Estados Unidos